A prospective study on application of human umbilical cord mesenchymal stem cells combined with autologous Meek microskin transplantation in patients with extensive burns

Yan Tiantian; Xiao Rong; Wang Ying; Lin Guo'an; Zheng Yin; Zhao Hui; Li Wenjun; Shang Xinzhi; Meng Jinsong; Hu Dongsheng; Li Song; Wang Chao; Lin Zhichen; Chen Hongchang; Zhao Dongyan; Tang Di

doi:10.3760/cma.j.cn501225-20220728-00319

Volume 39 Issue 2

Feb. 2023

Turn off MathJax

Article Contents

Article Navigation > CHINESE JOURNAL OF BURNS AND WOUNDS > 2023 > 39(2): 114-121

Yan TT,Xiao R,Wang Y,et al.A prospective study on application of human umbilical cord mesenchymal stem cells combined with autologous Meek microskin transplantation in patients with extensive burns[J].Chin J Burns Wounds,2023,39(2):114-121.DOI: 10.3760/cma.j.cn501225-20220728-00319.

Citation:

PDF( 16789 KB)

A prospective study on application of human umbilical cord mesenchymal stem cells combined with autologous Meek microskin transplantation in patients with extensive burns

doi: 10.3760/cma.j.cn501225-20220728-00319

1.
Military Burn Center, the 990th Hospital of PLA Joint Logistics Support Force, Zhumadian 463002, China
2.
Beijing Zhongjing Hi-Tech Biotechnology Co., Beijing 100089, China
3.
Henan Cellular Industry Technology Research Institute Co., Zhengzhou 450121, China
4.
Department of BurnsPlastic Surgery, PLA General Hospital of Central Theater Command, Wuhan 430012, China

Funds:

Military Medical Science and Technology Youth Incubation Program 20QNPY074

More Information

Corresponding author: Xiao Rong, Email: xr131@hotmail.com; Wang Ying, Email: 2669970157@qq.com
Received Date: 2022-07-28

Abstract

Abstract

Objective To investigate the effects of human umbilical cord mesenchymal stem cells (hUCMSCs) combined with autologous Meek microskin transplantation on patients with extensive burns. Methods The prospective self-controlled study was conducted. From May 2019 to June 2022, 16 patients with extensive burns admitted to the 990^th Hospital of PLA Joint Logistics Support Force met the inclusion criteria, while 3 patients were excluded according to the exclusion criteria, and 13 patients were finally selected, including 10 males and 3 females, aged 24-61 (42±13) years. A total of 20 trial areas (40 wounds, with area of 10 cm×10 cm in each wound) were selected. Two adjacent wounds in each trial area were divided into hUCMSC+gel group applied with hyaluronic acid gel containing hUCMSCs and gel only group applied with hyaluronic acid gel only according to the random number table, with 20 wounds in each group. Afterwards the wounds in two groups were transplanted with autologous Meek microskin grafts with an extension ratio of 1∶6. In 2, 3, and 4 weeks post operation, the wound healing was observed, the wound healing rate was calculated, and the wound healing time was recorded. The specimen of wound secretion was collected for microorganism culture if there was purulent secretion on the wound post operation. In 3, 6, and 12 months post operation, the scar hyperplasia in wound was assessed using the Vancouver scar scale (VSS). In 3 months post operation, the wound tissue was collected for hematoxylin-eosin (HE) staining to observe the morphological changes and for immunohistochemical staining to observe the positive expressions of Ki67 and vimentin and to count the number of positive cells. Data were statistically analyzed with paired samples t test and Bonferronni correction. Results In 2, 3, and 4 weeks post operation, the wound healing rates in hUCMSC+gel group were (80±11)%, (84±12)%, and (92±9)%, respectively, which were significantly higher than (67±18)%, (74±21)%, and (84±16)% in gel only group (with t values of 4.01, 3.52, and 3.66, respectively, P<0.05). The wound healing time in hUCMSC+gel group was (31±11) d, which was significantly shorter than (36±13) d in gel only group (t=-3.68, P<0.05). The microbiological culture of the postoperative wound secretion specimens from the adjacent wounds in 2 groups was identical, with negative results in 4 trial areas and positive results in 16 trial areas. In 3, 6, and 12 months post operation, the VSS scores of wounds in gel only group were 7.8±1.9, 6.7±2.1, and 5.4±1.6, which were significantly higher than 6.8±1.8, 5.6±1.6, and 4.0±1.4 in hUCMSC+gel group, respectively (with t values of -4.79, -4.37, and -5.47, respectively, P<0.05). In 3 months post operation, HE staining showed an increase in epidermal layer thickness and epidermal crest in wound in hUCMSC+gel group compared with those in gel only group, and immunohistochemical staining showed a significant increase in the number of Ki67 positive cells in wound in hUCMSC+gel group compared with those in gel only group (t=4.39, P<0.05), with no statistically significant difference in the number of vimentin positive cells in wound between the 2 groups (P>0.05). Conclusions The application of hyaluronic acid gel containing hUCMSCs to the wound is simple to perform and is therefore a preferable route. Topical application of hUCMSCs can promote healing of the autologous Meek microskin grafted area in patients with extensive burns, shorten wound healing time, and alleviate scar hyperplasia. The above effects may be related to the increased epidermal thickness and epidermal crest, and active cell proliferation.
- Burns,
- Cicatrix,
- Mesenchymal stem cell transplantation,
- Skin transplantation,
- Meek microskin

FullText(HTML)

References(32)

References

[1]	QuinteroEC,MachadoJFE,RoblesRAD.Meek micrografting history, indications, technique, physiology and experience: a review article[J].J Wound Care,2018,27(Sup2):S12-18.DOI: 10.12968/jowc.2018.27.Sup2.S12.
[2]	LeeSZ,HalimAS.Superior long term functional and scar outcome of Meek micrografting compared to conventional split thickness skin grafting in the management of burns[J].Burns,2019,45(6):1386-1400.DOI: 10.1016/j.burns.2019.04.011.
[3]	中华医学会烧伤外科学分会MEEK植皮技术中心协作组,海军军医大学第一附属医院烧伤外科,全军烧伤研究所.MEEK微型皮片移植技术临床操作规范[J].中华烧伤杂志,2019,35(8):561-564.DOI: 10.3760/cma.j.issn.1009-2587.2019.08.001.
[4]	陈德云体外诱导人脐带间充质干细胞分化为表皮样细胞北京解放军医学院2015 陈德云. 体外诱导人脐带间充质干细胞分化为表皮样细胞[D].北京:解放军医学院,2015.
[5]	许永安,黄沙,付小兵,等.特定微环境诱导人脐带沃顿胶间充质干细胞向汗腺样细胞分化的实验研究[J].解放军医学杂志,2011,36(3):211-214.
[6]	SuzdaltsevaY,ZhidkihS,KiselevSL,et al.Locally delivered umbilical cord mesenchymal stromal cells reduce chronic inflammation in long-term nonhealing wounds: a randomized study[J].Stem Cells Int,2020,2020:5308609.DOI: 10.1155/2020/5308609.
[7]	中国整形美容协会瘢痕医学分会.瘢痕早期治疗全国专家共识(2020版)[J].中华烧伤杂志,2021,37(2):113-125.DOI: 10.3760/cma.j.cn501120-20200609-00300.
[8]	Nagamura-InoueT,MukaiT.Umbilical cord is a rich source of mesenchymal stromal cells for cell therapy[J].Curr Stem Cell Res Ther,2016,11(8):634-642.DOI: 10.2174/1574888x10666151026115017.
[9]	史浩,胡葵葵.脐带间充质干细胞促进创面愈合的实验研究[J].中国医学工程,2014,22(5):57.
[10]	李云霞.脐带间充质干细胞对皮肤创伤愈合影响的实验研究[J].中国美容医学,2016,25(7):51-53.
[11]	YangY,ZhuS,LiY,et al.Human umbilical cord mesenchymal stem cells ameliorate skin fibrosis development in a mouse model of bleomycin-induced systemic sclerosis[J].Exp Ther Med,2020,20(6):257.DOI: 10.3892/etm.2020.9387.
[12]	ChenY,HuY,ZhouX,et al.Human umbilical cord-derived mesenchymal stem cells ameliorate psoriasis-like dermatitis by suppressing IL-17-producing γδ T cells[J].Cell Tissue Res,2022,388(3):549-563.DOI: 10.1007/s00441-022-03616-x.
[13]	BartolucciJ,VerdugoFJ,GonzálezPL,et al.Safety and efficacy of the intravenous infusion of umbilical cord mesenchymal stem cells in patients with heart failure: a phase 1/2 randomized controlled trial (RIMECARD trial [randomized clinical trial of intravenous infusion umbilical cord mesenchymal stem cells on cardiopathy])[J].Circ Res,2017,121(10):1192-1204.DOI: 10.1161/CIRCRESAHA.117.310712.
[14]	ChinSP,Mohd-ShahrizalMY,LiyanaMZ,et al.High dose of intravenous allogeneic umbilical cord-derived mesenchymal stem cells (CLV-100) infusion displays better immunomodulatory effect among healthy volunteers: a phase 1 clinical study[J].Stem Cells Int,2020,2020:8877003.DOI: 10.1155/2020/8877003.
[15]	HuP,YangQ,WangQ,et al.Mesenchymal stromal cells-exosomes: a promising cell-free therapeutic tool for wound healing and cutaneous regeneration[J/OL].Burns Trauma,2019,7:38[2022-07-28].https://pubmed.ncbi.nlm.nih.gov/31890717/.DOI: 10.1186/s41038-019-0178-8.
[16]	HuangD,YiZ,HeX,et al.Distribution of infused umbilical cord mesenchymal stem cells in a rat model of renal interstitial fibrosis[J].Ren Fail,2013,35(8):1146-1150.DOI: 10.3109/0886022X.2013.815109.
[17]	LeeRH,PulinAA,SeoMJ,et al.Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6[J].Cell Stem Cell,2009,5(1):54-63.DOI: 10.1016/j.stem.2009.05.003.
[18]	JungJW,KwonM,ChoiJC,et al.Familial occurrence of pulmonary embolism after intravenous, adipose tissue-derived stem cell therapy[J].Yonsei Med J,2013,54(5):1293-1296.DOI: 10.3349/ymj.2013.54.5.1293.
[19]	FurlaniD,UgurlucanM,OngL,et al.Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy[J].Microvasc Res,2009,77(3):370-376.DOI: 10.1016/j.mvr.2009.02.001.
[20]	OellerM,Laner-PlambergerS,HochmannS,et al.Selection of tissue factor-deficient cell transplants as a novel strategy for improving hemocompatibility of human bone marrow stromal cells[J].Theranostics,2018,8(5):1421-1434.DOI: 10.7150/thno.21906.
[21]	DuanJX, LiuWJ, ZengYQ, et al. Umbilical cord mesenchymal stem cells (hUCMSC) for inflammatory regulation after excision and grafting of severe burn wounds in rats[J]. J Burn Care Res, 2020, 42(4):766-773. DOI: 10.1093/jbcr/iraa207.
[22]	LiuL,YuY,HouY,et al.Human umbilical cord mesenchymal stem cells transplantation promotes cutaneous wound healing of severe burned rats[J].PLoS One,2014,9(2):e88348.DOI: 10.1371/journal.pone.0088348.
[23]	李梦芸,刘德伍,毛远桂.干细胞源性外泌体在创面修复中的作用研究进展[J].中华烧伤杂志,2017,33(3):180-184.DOI: 10.3760/cma.j.issn.1009-2587.2017.03.013.
[24]	LiuSJ,MengMY,HanS,et al.Umbilical cord mesenchymal stem cell-derived exosomes ameliorate HaCaT cell photo-aging[J].Rejuvenation Res,2021,24(4):283-293.DOI: 10.1089/rej.2020.2313.
[25]	ShoharaR,YamamotoA,TakikawaS,et al.Mesenchymal stromal cells of human umbilical cord Wharton's jelly accelerate wound healing by paracrine mechanisms[J].Cytotherapy,2012,14(10):1171-1181.DOI: 10.3109/14653249.2012.706705.
[26]	WangM,XuX,LeiX,et al.Mesenchymal stem cell-based therapy for burn wound healing[J/OL].Burns Trauma,2021,9:tkab002[2022-07-28].https://pubmed.ncbi.nlm.nih.gov/34212055/.DOI: 10.1093/burnst/tkab002.
[27]	王配合,彭毅志.烧伤创面痂下活组织细菌定量培养与植皮存活率分析[J].中华烧伤杂志,2004,20(1):45-46.DOI: 10.3760/cma.j.issn.1009-2587.2004.01.017.
[28]	CookN.Methicillin-resistant Staphylococcus aureus versus the burn patient[J].Burns,1998,24(2):91-98.DOI: 10.1016/s0305-4179(97)00114-9.
[29]	OhH,BooS.Assessment of burn-specific health-related quality of life and patient scar status following burn[J].Burns,2017,43(7):1479-1485.DOI: 10.1016/j.burns.2017.03.023.
[30]	WangY,BeekmanJ,HewJ,et al.Burn injury: challenges and advances in burn wound healing, infection, pain and scarring[J].Adv Drug Deliv Rev,2018,123:3-17.DOI: 10.1016/j.addr.2017.09.018.
[31]	沙焱, 谢英, 陈志军, 等. 脐带间充质干细胞对矽肺大鼠肺纤维化的干预研究 [J].中华劳动卫生职业病杂志,2019,37 (6): 401-407. DOI: 10.3760/cma.j.issn.1001-9391.2019.06.001.
[32]	HouschyarKS,TapkingC,NietzschmannI,et al.Five years experience with Meek grafting in the management of extensive burns in an adult burn center[J].Plast Surg(Oakv),2019,27(1):44-48.DOI: 10.1177/2292550318800331.